The methylation class glioma IDH-mutant comprised 48% (51/106) 1p/19q codeleted oligodendroglioma tumors, 45% (48/106) astrocytoma and 7% (7/106) high-grade astrocytoma (Fig. 2c). The gene discussed is IDH2; the disease is central nervous system cancer.